Advanced Search


Study ID Status Title Patient Level Data
109509 Completed Booster vaccination course with the pneumococcal vaccine GSK 1024850A, DTPw-HBV/Hib and OPV or IPV in children who completed the primary vaccination course in study 107007 Study Listed on
109551 Completed A Hospital-based surveillance to collect prospective data to estimate the disease burden of severe rotavirus (RV) gastroenteritis (GE), its complications and diversity of co-circulating rotavirus strains in children < 5 years of age in Sweden
109563 Completed COMPAS: A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Study Listed on
109609 Terminated A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects with Advanced Non-Small Cell Lung Cancer
109616 (Y7) Completed Follow-up study to evaluate the long-term efficacy of a HPV vaccine (580299) in healthy young adult women in Brazil Study Listed on
109621 Completed Safety, reactogenicity and immunogenicity following booster dose of GSK Biologicals´ pneumococcal conjugate vaccine when co-administered with a booster dose of Infanrix-IPV/Hib in preterm born children at 16-18 months of age Study Listed on
109628 Completed Safety and immunogenicity study of an additional dose of HPV vaccine (580299) in young, adult women in North America. Study Listed on
109630 Completed Assess the consistency of the immunogenicity of a GlaxoSmithKline Biologicals' pandemic influenza vaccine (GSK1562902A) in adults aged between 18 and 60 years Study Listed on
109652 Completed A single-centre open label study to investigate the effect of repeat doses of SB-649868 on the pharmacokinetics of Simvastatin and Atorvastatin in healthy male volunteers. Study Listed on
109661 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A, Infanrix hexa and Rotarix Study Listed on
109664 Completed Assessment of long-term antibody persistence after a booster dose of GSK Biologicals’ Hib & meningococcal C vaccine (Menitorix™) 811936 given at 12-15 months of age to subjects primed with 3 doses of Menitorix™ at 2, 3, 4 months of age Study Listed on
109670 Relinquished Immunogenicity & Safety Study of GSK Biologicals' Meningococcal Vaccine GSK134612 When co-Administered With GSK Biologicals' MMRV Vaccine (Priorix-Tetra™) in Healthy 12 to 23-Month-Old Children Study Listed on
109671 Completed An extension study to evaluate the persistence of the immune responses induced by GSK Biologicals Zoster vaccine, GSK324332A, administered in healthy adult subjects aged 18-30 years and 50-70 years
109693 Completed A Phase I, Open-Label, Multiple Dose of Pazopanib Alone and In Combination with Lapatinib in Japanese Patients with Solid Tumors
109705 Completed Study of two formulations of GSK Biologicals' varicella vaccine given as a 2-dose course in the second year of life Study Listed on
109709 Withdrawn A placebo-controlled, single-blind, cross-over, randomised, fMRI study comparing cue-induced brain activation patterns after a single oral dose of GSK598809 or placebo in abstinent alcoholic subjects
109710 Completed A single-blind, randomized, placebo controlled, two-period crossover fMRI study to investigate the effects of the D3 antagonist GSK598809 on neural and behavioural responses to food reward and reinforcement after a single oral dose of GSK598809 in overweight and obese subjects. Study Listed on
109731 Completed An adaptive PET study in healthy volunteers using [11C]GSK931145 to establish the relationship of Glycine Transporter 1 occupancy by GSK1018921 to plasma concentrations over time. Study Listed on
109737 Completed The effectiveness of varicella vaccination in children in Germany
109749 Completed Clinical Evaluation of Lapatinib Administered with Capecitabine in Japanese Patients with ErbB2 overexpressing Advanced or Metastatic Breast Cancer
109752 Terminated Analysis of the expression of a specific set of genes and tumor antigens in patients with non-small cell lung cancer or melanoma
109780 Completed Follow-up survey to compare stable dosing (SERETIDE) with SYMBICORT SMART, maintenance and reliever therapy in one inhaler in moderate and severe asthmatics.
109801 Completed Complementary testing to further evaluate the immunogenicity of a GSK Biologicals’ HPV vaccine (580299) in healthy female subjects aged over 26 years enrolled in study 104820. Study Listed on
109810 Completed To assess long-term efficacy & safety of subjects approximately 3 years after priming with 2 doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine (Rotarix) in the primary vaccination study (102247). Study Listed on
109817 Completed Evaluate the reactogenicity & immunogenicity of 1 or 2 booster administrations of an influenza pandemic candidate vaccine (GSK1562902A) in primed adults aged between 19 & 61 years Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.